Clinical trial
Study for Patients With Non Small Cell Lung Cancer (NSCLC)
NCT00168883 · Charite University, Berlin, Germany, Other · Unknown status
Key facts
| NCT number | NCT00168883 |
|---|---|
| Title | Study for Patients With Non Small Cell Lung Cancer (NSCLC) |
| Official title | Randomized Phase II Study to Determine the Efficacy of a Three Weekly vs. Weekly Therapy With Paclitaxel Plus Carboplatin vs. Paclitaxel Plus Vinorelbine for Patients With Non Small Cell Lung Cancer According to UICC Stage IIIB and IV |
| Lead sponsor | Charite University, Berlin, Germany, Other |
| Collaborators | Bristol-Myers Squibb Industry Pierre Fabre Pharma GmbH |
| Status | Unknown status |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Carcinoma, Non-Small-Cell Lung |
| Intervention type | Drug |
| Interventions | Carboplatin, Paclitaxel, Vinorelbine |
| Enrollment | 80 |
| Start date | Oct 1, 2002 |
| Completion | Dec 1, 2006 |
| First posted | Sep 15, 2005 |
| Last update posted | Nov 1, 2006 |
| Countries | Germany |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: